Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could rosemary help tame diabetes inflammation?

NCT ID NCT07541729

Disease control Sponsor: Universidad Autonoma de Zacatecas Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This early-stage trial is testing whether a rosemary extract supplement can improve markers of oxidative stress and inflammation in people with type 2 diabetes. Forty adults with stable diabetes will take either the extract or a placebo for 12 weeks. The study focuses on blood biomarkers, not direct health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
rosemary extract
What this could lead to
If it works, this could point toward a natural supplement to help manage oxidative stress and inflammation in type 2 diabetes.
What could go wrong
This is a very early phase 1 trial with only 40 people, so results may not be conclusive. It's testing biomarkers, not clinical outcomes, so even positive results may not translate to real-world benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Sep 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Confirmed diagnosis of T2DM 2. Older adults over the age of 18. 3. Signed Informed Consent (Annex 1) 4. Clinical stability or absence of acute complications associated with diabetes or another disease at the time of the study. 5. Absence of other associated diseases except Obesity and/or Hypertension 6. Glomerular filtration rate greater than or equal to 60ml/min/1.73m2 according to the CKD-EPI 2021 formula Exclusion Criteria: 1. Allergy or hypersensitivity to any of the components of Rosemary. 2. Pregnant or breastfeeding women. 3. Patients who are taking other supplements or medications that may interfere with the study results. (antioxidants) 5\. Patients who are participating in another clinical trial simultaneously.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inflammation chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inflammation chronic Oxidative stress Type 2 diabetes mellitus (T2DM)

Contacts and locations

Locations

  • ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado)

    Zacatecas City, Zacatecas, 98160, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.